ContextVision - Strong Q3 with solid sales, good inflow of new customers and first product in digital pathology enters beta-testing phase
STOCKHOLM – October 24, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, has seen a strong third quarter in 2019 as new customers have been added and the first product in digital pathology has entered the beta-testing phase. Q3 sales reached 23 MSEK and total sales are growing +5% compared to the third quarter last year. The operating result was positive 4.6 MSEK. “ContextVision continues to see solid sales as we build out our product portfolio and add new customers. ContextVision is committed to expanding the product